Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1

Interventions

Cyclophosphamide 12Rituximab 10obinutuzumab 6fludarabine phosphate 6Prednisone 6fludarabine 5X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Melphalan 5Magnetic Resonance Spectroscopy 5Lenalidomide 5Etoposide 5Biopsy 5tocilizumab 4ibrutinib 4Whole-Body Irradiation 4Doxorubicin 4venetoclax 3polatuzumab vedotin 3glofitamab 3Mycophenolic Acid 3Leukapheresis 3Filgrastim 3Cytarabine 3Cyclosporine 3Busulfan 3Bendamustine Hydrochloride 3ulixertinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × rasburicase × 30 days × Clear all
NCT01046825 2026-06-02

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡